| Literature DB >> 20085308 |
Alessandra S Eustáquio1, David O'Hagan, Bradley S Moore.
Abstract
Organofluorine compounds play an important role in medicinal chemistry, where they are responsible for up to 15% of the pharmaceutical products on the market. While natural products are valuable sources of new chemical entities, natural fluorinated molecules are extremely rare and the pharmaceutical industry has not benefited from a microbial source of this class of compounds. Streptomyces cattleya is an unusual bacterium in that it elaborates fluoroacetate and the amino acid 4-fluorothreonine. The discovery in 2002 of the fluorination enzyme FlA responsible for C-F bond formation in S. cattleya, and its subsequent characterization, opened up for the first time the prospect of genetically engineering fluorometabolite production from fluoride ion in host organisms. As a proof of principle, we report here the induced production of fluorosalinosporamide by replacing the chlorinase gene salL from Salinispora tropica with the fluorinase gene flA.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20085308 PMCID: PMC2846182 DOI: 10.1021/np900719u
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050